Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisomal targeting signal 1 receptor (PEX5) is a cytosolic receptor essential for peroxisomal matrix protein import. PEX5 recognizes and binds proteins carrying a C-terminal peroxisomal targeting signal 1 (PTS1), typically a Ser-Lys-Leu (SKL)-type tripeptide, and transports them from the cytosol into peroxisomes by interacting with the peroxisomal membrane docking complexes, primarily PEX13 and PEX14[1][3][4]. A longer isoform (PEX5L) also facilitates the import of peroxisomal PTS2-protein complexes via interaction with another peroxin, PEX7[3]. PEX5 plays a critical role in peroxisome biogenesis and function; pathogenic variants in PEX5 cause inherited peroxisome biogenesis disorders, notably Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease[1][3]. Defective PEX5 activity results in disruption of peroxisomal protein import and multisystem metabolic disease[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal targeting signal 1 receptor (PEX5).